Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under ...

Most Americans have health insurance, but that doesn't ease fears of a medical emergency pushing them to the financial brink, ...

Regeneron will cut the price of its cholesterol-lowering treatment Praluent to $225, down from $537, on the TrumpRx website.

Regeneron will make its newly approved gene therapy available for free in the U.S. The company hasn't yet decided how much it ...

The administration Apri 23 reached a most-favored-nation drug pricing agreement with Regeneron, the maker of the popular cholesterol medicine Praluent. This is the 17th such agreement by a drug ...

Dr. David Kalfa, a professor and researcher at FIU Medicine and chief of cardiovascular surgery and co-director of the ...